Novel Point Mutations in 3′-Untranslated Region of GATA4 Gene Are Associated with Sporadic Non-syndromic Atrial and Ventricular Septal Defects

Abstract

Objective

Transcription factor GATA4 has significant roles in embryonic heart development. Mutations of GATA4 appear to be responsible for a wide variety of congenital heart defects (CHD). Despite the high prevalence of GATA4 mutations in CHD phenotypes, extensive studies have not been performed. The 3′-untranslated region (3′-UTR) of the GATA4 gene comprises regulatory motifs and microRNA binding sites that are critical for the appropriate gene expression, nuclear transportation, and regulation of translation, and stability of mRNA. This study aimed to evaluate the association between mutations in the 3′-UTR of the GATA4 gene and CHD risk among Iranian patients.

Methods

We analyzed the coding region of exon 6 and the whole 3′-UTR of GATA4 in DNA isolated from 175 blood samples of CHD patients and 115 unrelated healthy individuals. The functional importance of the observed GATA4 mutations was evaluated using a variety of bioinformatics algorithms for assessment of nonsynonymous mutations and those observed in miRNA binding sites of 3′-UTR.

Results

Twenty-one point mutations including one missense mutation (c.511A>G: p.Ser377Gly) in exon 6 and 20 nucleotide variations in 3′-UTR of GATA4 gene were identified in 65 of the 175 CHD patients. In our patients, we identified 12 novel sequence alterations and 8 single nucleotide polymorphisms in the 3′-UTR of GATA4. Most of them had statistically significant differences between CHD patients and controls.

Conclusion

Our results suggest that 3′-UTR variations of the GATA4 gene probably change microRNA binding sites and present an additional molecular risk factor for the susceptibility of CHD.

Keywords

congenital heart disease / GATA4 / 3′-untranslated region / mutation / in-silico analysis

References

[1] BestKE, RankinJ. Long-Term Survival of Individuals Born With Congenital Heart Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc, 2016, 5(6): e002846

[2] TriedmanJK, NewburgerJW. Trends in Congenital Heart Disease: The Next Decade. Circulation, 2016, 133(25): 2716-2733

[3] AkhiromeE, WaltonNA, NogeeJM, et al.. The Complex Genetic Basis of Congenital Heart Defects. Circ J, 2017, 81(5): 629-634

[4] PierpontME, BassonCT, BensonDWJr., et al.. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation, 2007, 115(23): 3015-3038

[5] NashatH, MontanaroC, LiW, et al.. Atrial septal defects and pulmonary arterial hypertension. J Thorac Dis, 2018, 10(Suppl24): S2953-S2965

[6] VecoliC, PulignaniS, FoffaI, et al.. Congenital heart disease: the crossroads of genetics, epigenetics and environment. Curr Genomics, 2014, 15(5): 390-399

[7] BruneauBG. Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harb Perspect Biol, 2013, 5(3): a008292

[8] PaigeSL, PlonowskaK, XuA, et al.. Molecular regulation of cardiomyocyte differentiation. Circ Res, 2015, 116(2): 341-353

[9] MaL, WangJ, LiL, et al.. ISL1 loss-of-function mutation contributes to congenital heart defects. Heart Vessels, 2019, 34(4): 658-668

[10] WangZ, SongHM, WangF, et al.. A New ISL1 Loss-of-Function Mutation Predisposes to Congenital Double Outlet Right Ventricle. Int Heart J, 2019, 60(5): 1113-1122

[11] BrandT. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol, 2003, 258(1): 1-19

[12] Granados-RiveronJT, PopeM, Bu’lockFA, et al.. Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations. Congenit Heart Dis, 2012, 7(2): 151-159

[13] ZhangY, SunYM, XuYJ, et al.. A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block. Int Heart J, 2020, 61(4): 761-768

[14] SchaanCW, MacedoACP, SbruzziG, et al.. Functional Capacity in Congenital Heart Disease: A Systematic Review and Meta-Analysis. Arq Bras Cardiol, 2017, 109(4): 357-367

[15] MisraC, SachanN, McNallyCR, et al.. Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet, 2012, 8(5): e1002690

[16] WangE, SunS, QiaoB, et al.. Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS One, 2013, 8(4): e62138

[17] YangYQ, WangJ, LiuXY, et al.. Novel GATA4 mutations in patients with congenital ventricular septal defects. Med Sci Monit, 2012, 18(6): CR344-350

[18] Tomita-MitchellA, MaslenCL, MorrisCD, et al.. GATA4 sequence variants in patients with congenital heart disease. J Med Genet, 2007, 44(12): 779-783

[19] KhatamiM, MazidiM, TaherS, et al.. Novel Point Mutations in the NKX2.5 Gene in Pediatric Patients with Non-Familial Congenital Heart Disease. Medicina (Kaunas), 2018, 54(3): 46

[20] KhatamiM, HeidariMM, KazeminasabF, et al.. Identification of a novel non-sense mutation in TBX5 gene in pediatric patients with congenital heart defects. J Cardiovasc Thorac Res, 2018, 10(1): 41-45

[21] DianatpourS, KhatamiM, HeidariMM, et al.. Novel Point Mutations of CITED2 Gene Are Associated with Non-familial Congenital Heart Disease (CHD) in Sporadic Pediatric Patients. Appl Biochem Biotechnol, 2019, 190(3): 896-906

[22] Reamon-BuettnerSM, ChoSH, BorlakJ. Mutations in the 3′-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet, 2007, 8: 38

[23] SchwerkJ, SavanR. Translating the Untranslated Region. J Immunol, 2015, 195(7): 2963-2971

[24] PulignaniS, VecoliC, SabinaS, et al.. 3′UTR SNPs and Haplotypes in the GATA4 Gene Contribute to the Genetic Risk of Congenital Heart Disease. Rev Esp Cardiol (Engl Ed), 2016, 69(8): 760-765

[25] QuL, LiX, WuG, et al.. Efficient and sensitive method of DNA silver staining in polyacrylamide gels. Electrophoresis, 2005, 26(1): 99-101

[26] LentjesMH, NiessenHE, AkiyamaY, et al.. The emerging role of GATA transcription factors in development and disease. Expert Rev Mol Med, 2016, 18: e3

[27] ValimakiMJ, RuskoahoHJ. Targeting GATA4 for cardiac repair. IUBMB Life, 2020, 72(1): 68-79

[28] PatientRK, McGheeJD. The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev, 2002, 12(4): 416-422

[29] PeterkinT, GibsonA, LooseM, et al.. The roles of GATA-4, -5 and -6 in vertebrate heart development. Semin Cell Dev Biol, 2005, 16(1): 83-94

[30] MattapallyS, NizamuddinS, MurthyKS, et al.. c.620C>T mutation in GATA4 is associated with congenital heart disease in South India. BMC Med Genet, 2015, 16: 7

[31] OkuboA, MiyoshiO, BabaK, et al.. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet, 2004, 41(7): e97

[32] RajagopalSK, MaQ, OblerD, et al.. Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol, 2007, 43(6): 677-685

[33] WangJ, FangM, LiuXY, et al.. A novel GATA4 mutation responsible for congenital ventricular septal defects. Int J Mol Med, 2011, 28(4): 557-564

[34] GargV, KathiriyaIS, BarnesR, et al.. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature, 2003, 424(6947): 443-447

[35] Al-AzzounyMA, El RubyMO, IssaHA, et al.. Detection and putative effect of GATA4 gene variants in patients with congenital cardiac septal defects. Cell Mol Biol (Noisy-le-grand), 2016, 62(3): 10-14

[36] BoseD, D V, ShettyM, et al.. Identification of intronic-splice site mutations in GATA4 gene in Indian patients with congenital heart disease. Mutat Res, 2017, 803–805: 26-34

[37] CiccacciC, RufiniS, PolitiC, et al.. Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes. Thromb Res, 2015, 136(2): 367-370

[38] ChatterjeeS, PalJK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell, 2009, 101(5): 251-262

[39] FelekkisK, TouvanaE, StefanouC, et al.. microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia, 2010, 14(4): 236-240

[40] MoszynskaA, GebertM, CollawnJF, et al.. SNPs in microRNA target sites and their potential role in human disease. Open Biol, 2017, 7(4): 170019

[41] NuryD, ChabanonH, Levadoux-MartinM, et al.. An eleven nucleotide section of the 3′-untranslated region is required for perinuclear localization of rat metallothionein-1 mRNA. Biochem J, 2005, 387: 419-428

[42] SabinaS, PulignaniS, RizzoM, et al.. Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects. J Mol Cell Cardiol, 2013, 60: 84-89